Our highly anticipated Clinical Operations in Oncology Trials conference is returning for its 3rd annual event and promises to be an engaging and memorable conference. Building on the tremendous success of previous years, this exclusively tailored event will focus on real practical examples for improved clinical operation excellence, assess market challenges and explore new areas of innovation. Central to this year’s conference, we will be focusing on: enhancing patient recruitment and retention, supporting the development of strategic partnerships, improved operational strategies e.g. adaptive trials, global site selection, feasibility assessment, alongside delving into key regulatory and review board guidelines

Delving into key issues in the operation of oncology trials, the conference agenda will resonate well with pharmaceutical sponsors, biotechnology representatives and vendors alike. This event will also provide a unique platform for networking with key decision-makers alongside offering a unique opportunity to learn from high profile, senior-level industry professionals.